Report cover image

Global CMO/CDMO Biotechnology Market - 2024-2033

Published Mar 18, 2026
Length 210 Pages
SKU # DTAM21122540

Description

Global CMO/CDMO Biotechnology Market Overview:
The Global CMO/CDMO Biotechnology Market was valued at US$ 14.32Billion in 2024 and is anticipated to reach US$ 37.53Billion by 2033, at a CAGR of 0.113 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Global CMO/CDMO Biotechnology Market.

This report delivers a comprehensive overview of the Global CMO/CDMO Biotechnology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Global CMO/CDMO Biotechnology Market. The Global CMO/CDMO Biotechnology Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Global CMO/CDMO Biotechnology Market Scope:
Key Players
• Catalent
• Samsung Biologics Co., Ltd
• Lonza.
• Boehringer Ingelheim
• AGC Biologics, Inc.
• Patheon N.V.
• WuXi Biologics
• AbbVie Inc
• Avid Bio services, Inc.
• Fujifilm Diosynth Biotechnologies

Major Highlights
This report delivers a comprehensive overview of the Global CMO/CDMO Biotechnology Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Global CMO/CDMO Biotechnology Market. The Global CMO/CDMO Biotechnology Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

210 Pages
1. Market Introduction and Scope
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. Executive Insights and Key Takeaways
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product
2.4. Snippet by Service
2.5. Snippet by Company Size
2.6. Snippet by Scale of Operation
2.7. Snippet by Expression System
2.8. Snippet by Region
3. Dynamics
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Demand for Biologics and Biosimilars
3.1.1.2. Advances in Bioprocessing Technologies
3.1.2. Restraints
3.1.2.1. High Capital Intensity & Complex Manufacturing
3.1.2.2. Stringent Regulatory Compliance
3.1.3. Opportunity
3.1.3.1. Expansion into Emerging Markets
3.1.3.2. Integrated Development-to-Commercialization Services
3.1.4. Impact Analysis
4. Strategic Insights and Industry Outlook
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established Leaders with the Largest Marketing Brand
4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Patent Analysis
4.6. Unmet Needs and Gaps
4.7. Recommended Strategies for Market Entry and Expansion
4.8. Pricing Analysis and Price Dynamics
5. CMO/CDMO Biotechnology Market, By Product
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
5.1.2. Market Attractiveness Index, By Product
5.2. Small Molecules*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Large Molecules
6. CMO/CDMO Biotechnology Market, By Service
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
6.1.2. Market Attractiveness Index, By Service
6.2. Standalone Services*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Integrated Services
7. CMO/CDMO Biotechnology Market, By Company Size
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Company Size
7.1.2. Market Attractiveness Index, By Company Size
7.2. Small*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Mid-sized
7.4. Large
8. CMO/CDMO Biotechnology Market, By Scale of Operation
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Scale of Operation
8.1.2. Market Attractiveness Index, By Scale of Operation
8.2. Preclinical*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinical
8.4. Commercial
9. CMO/CDMO Biotechnology Market, By Expression System
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
9.1.2. Market Attractiveness Index, By Expression System
9.2. Mammalian*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Microbial
10. CMO/CDMO Biotechnology Market, By Regional Market Analysis and Growth Opportunities
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Company Size
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Scale of Operation
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.8.1. U.S.
10.2.8.2. Canada
10.2.8.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Company Size
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Scale of Operation
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.8.1. Germany
10.3.8.2. UK
10.3.8.3. France
10.3.8.4. Spain
10.3.8.5. Italy
10.3.8.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Company Size
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Scale of Operation
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.8.1. China
10.4.8.2. India
10.4.8.3. Japan
10.4.8.4. South Korea
10.4.8.5. Rest of Asia-Pacific
10.5. South America
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Company Size
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Scale of Operation
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.8.1. Brazil
10.5.8.2. Argentina
10.5.8.3. Rest of South America
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Company Size
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Scale of Operation
10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
11. Competitive Landscape and Market Positioning
11.1. Competitive Overview and Key Market Players
11.2. Market Share Analysis and Positioning Matrix
11.3. Strategic Partnerships, Mergers & Acquisitions
11.4. Key Developments in Product Portfolios and Innovations
11.5. Company Benchmarking
12. Company Profiles
12.1. Catalent*
12.1.1. Company Overview
12.1.2. Product Portfolio
12.1.2.1. Product Description
12.1.2.2. Product Key Performance Indicators (KPIs)
12.1.3. Financial Overview
12.1.3.1. Company Revenue
12.1.3.2. Geographical Revenue Shares
12.1.3.3. Revenue Forecasts
12.1.4. Key Developments
12.1.4.1. Mergers & Acquisitions
12.1.4.2. Key Product Development Activities
12.1.4.3. Regulatory Approvals, etc.
12.1.5. SWOT Analysis
12.2. Samsung Biologics Co., Ltd
12.3. Lonza.
12.4. Boehringer Ingelheim
12.5. AGC Biologics, Inc.
12.6. Patheon N.V.
12.7. WuXi Biologics
12.8. AbbVie Inc
12.9. Avid Bio services, Inc.
12.10. Fujifilm Diosynth Biotechnologies (LIST NOT EXHAUSTIVE )
13. Assumptions and Research Methodology
13.1. Data Collection Methods
13.2. Data Triangulation
13.3. Forecasting Techniques
13.4. Data Verification and Validation
14. Appendix
14.1. About Us and Services
14.2. Contact Us
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.